Beacon Pharmaceuticals Cash Flow Statement

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Net Income	1,238	946.51	521.01	509.84	935.04	863.17
Depreciation & Amortization	631.4	631.4	527.78	518.92	439.7	385.16
Loss (Gain) From Sale of Assets	0.01	0.01	6.5	-3.07	-	-
Other Operating Activities	-93.32	153.83	287.23	-147.1	438.72	75.87
Change in Accounts Receivable	-50.52	-50.52	-767.59	-251.01	-30.72	-873.78
Change in Inventory	-435.6	-435.6	-895.97	-19.73	-693.28	-246.07
Change in Accounts Payable	-236.31	-236.31	680.87	191.87	-7.83	183.53
Change in Income Taxes	-	-	-	-	-169.84	162.23
Change in Other Net Operating Assets	590.71	590.71	-539.46	-178.55	170.39	-353.56
Operating Cash Flow	1,644	1,600	-179.63	621.18	1,082	196.56
Operating Cash Flow Growth	-10.38%	-	-	-42.60%	450.56%	-32.49%
Capital Expenditures	-917.14	-821.53	-1,095	-1,814	-1,719	-313.41
Sale of Property, Plant & Equipment	0.72	0.24	30.15	-	-	-
Sale (Purchase) of Intangibles	-1.2	-1.2	-25.22	-	-	-
Investment in Securities	333.38	-194.48	-1,276	-2,190	-118.52	-403.71
Other Investing Activities	-19.96	-	-0	39.83	-	3.24
Investing Cash Flow	-604.2	-1,017	-2,366	-3,965	-1,838	-713.87
Short-Term Debt Issued	-	-	-	-	1,529	349.06
Long-Term Debt Issued	-	-	2,864	3,628	-	-
Total Debt Issued	-	-	2,864	3,628	1,529	349.06
Long-Term Debt Repaid	-	-241.8	-	-	-199.71	-33.27
Total Debt Repaid	-423.7	-241.8	-	-	-199.71	-33.27
Net Debt Issued (Repaid)	-423.7	-241.8	2,864	3,628	1,330	315.79
Common Dividends Paid	-	-347.11	-369.56	-371.06	-373.53	-59.42
Other Financing Activities	22.81	-	-	-	-	-
Financing Cash Flow	-400.9	-588.9	2,494	3,257	956.25	256.37
Foreign Exchange Rate Adjustments	-25.55	-73.24	-93.69	-	-	-
Net Cash Flow	613.34	-79.09	-145.24	-86.31	200.66	-260.94
Free Cash Flow	726.84	778.5	-1,275	-1,193	-637.07	-116.85
Free Cash Flow Margin	4.92%	6.21%	-11.91%	-14.02%	-7.94%	-1.64%
Free Cash Flow Per Share	3.15	3.37	-5.52	-5.17	-2.76	-0.51
Cash Interest Paid	1,339	1,327	983.91	464.36	339.38	166.8
Cash Income Tax Paid	137.74	255.15	257.56	271.77	450.75	17.31
Levered Free Cash Flow	-535.29	-8.61	-3,111	-3,814	-1,146	-562.04
Unlevered Free Cash Flow	294.06	809.17	-2,484	-3,526	-934.37	-459.03
Change in Working Capital	-131.72	-131.72	-1,522	-257.42	-731.28	-1,128

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.